entity · release 2026-09-20

Lacticaseibacillus rhamnosus R-11

Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.

Across the corpus

How this organism is actually sold

Printed CFU per serving: 15,000,000,000 – 20,000,000,000; median 17,500,000,000. Measured on the 2 of 3 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
Cost per day: $1.1 – $1.1; median $1.1. Measured on the 1 of 3 published products carrying it with an observed price and a computable days-of-supply.
Forms: Capsule: 3 · counted across the 3 of 3 published products whose label states a form
Brands carrying it: aor-advanced-orthomolecular-research-advanced (1) · geri-care (1) · jarrow-formulas (1)
Published product pages: 3

Products

Published products carrying this organism

Product	Printed CFU	Printed dose	Cost per day	Form	Gut Index Score
Jarrow Formulas Jarro-Dophilus EPS 10 Billion CFU	not printed	not printed	$1.1	Capsule	63.40
AOR Advanced Orthomolecular Research Advanced Advanced Biotics	15,000,000,000	not printed	not observed	Capsule	49.61
Geri-Care Probiotic Digestive Support Extra Strength	20,000,000,000	not printed	not observed	Capsule	29.03

Reformulations

Label changes involving this organism

2 change(s) to this organism's own row, observed on 1 product(s). A change is counted only between two snapshots whose ingredient rows were both parsed; a first observation is not a change.

Jarrow Formulas Jarro-Dophilus EPS 10 Billion CFU: 307627 → 323063, organism added to the label
Jarrow Formulas Jarro-Dophilus EPS 10 Billion CFU: 307628 → 323063, organism added to the label

Containing labels3

Evidence amount0.00

Direction balanceThe direction of the study results has not been extracted.

Matched PubMed records

0 records (retracted records excluded; 0 retracted records match the query separately). PubMed query

Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.

No records match this query.

ClinicalTrials.gov

0 interventional studies. ClinicalTrials.gov query

This species has 57 tracked designations; this one appears on 3 labels (median 4).

Species and related strains

Lacticaseibacillus rhamnosus

Axis 1 · inverted

Containing label versions

Showing 3 of 3 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.

Brand	Product	DSLD	Gut Index Score	Strain named	Per-organism quantity	Potency basis	Versions
Jarrow Formulas	Jarro-Dophilus EPS 5 Billion CFU	323063	63.40	true	not printed for this organism	through expiry	3
AOR Advanced Orthomolecular Research Advanced	Advanced Biotics	214420	49.61	true	18,750,000,000 CFU	at manufacture	1
Geri-Care	Probiotic Digestive Support Extra Strength	309703	29.03	true	20,000,000,000 CFU	not stated	1

Axis 2

Studiedness

Evidence amount: 0.00
Direction balance: The direction of the study results has not been extracted.
PMID records loaded: 0
Records after title/year deduplication: 0

Axis 3

Measurement integrity

Not a measurement product, so this axis does not apply.

Axis 4

Reddit mention panel

0 observed mentions; no aggregate panel matched this entity.

Elsewhere in this release

Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps

Tools: DSLD product check · Unit value calculator

Citation

Cite this page

Ivitskiy, I. (2026). Lacticaseibacillus rhamnosus R-11. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lacticaseibacillus-rhamnosus-r-11/

The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.

Citable atoms

Release claims

Lacticaseibacillus rhamnosus R-11 appears on 3 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 3 brands; tied with 39 designations by distinct label count.
3 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
2 of 3 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lacticaseibacillus rhamnosus R-11 (66.7%); 0 light records have quantities unavailable.
2 / 3 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
No indexed strain-level randomized human trial report was found in this ledger version (as of 2026-09-15). 0 records (retracted records excluded; 0 retracted records match the query separately).
Published PubMed query
0 / 0 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
0 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
0 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
1 of 3 SKUs containing Lacticaseibacillus rhamnosus R-11 have a numeric price observation (33.3%) in the release accompanying the NIH DSLD snapshot Sep 2026.
1 / 3 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437

Back to the release hub